navigating the world of combination products (2of15) redi – may 29-30, 2019
Published 4 years ago • 8.3K plays • Length 1:14:28
Download video MP4
Download video MP3
Similar videos
-
36:06
what can cder do for you? (3of15) redi annual conference – may 29-30, 2019
-
10:31
ora aligned for the future (1of15) redi – may 29-30, 2019
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
41:30
meetings: pre-submission and special programs (4of15) redi annual conference – may 29-30, 2019
-
41:31
pre-approval inspections: what to expect when being inspected (15of15) redi – may 29-30, 2019
-
38:21
nda and bla application review process (6of15) redi annual conference – may 29-30, 2019
-
1:10:48
cmc - nda requirements and common pitfalls of blas (14of15) redi – may 29-30, 2019
-
23:33
combination products: reporting device information and malfunctions - pharmacovigilance 2020
-
35:01
combination products: user-interface & role of comparative analyses (29of39) complex generics 2018
-
47:42
generic combination products: assessment and regulatory update (14of16) gdf 2020
-
12:30
an overview of fda's patent listing process
-
5:41:06
redi annual conference 2024: cdrh (devices) innovation in medical product development (day 1 of 2)
-
6:52:20
redi annual conference 2024: cdrh (devices) innovation in medical product development (day 2 of 2)
-
34:20
a medical officer’s approach to nda/bla review (8of15) redi annual conference – may 29-30, 2019
-
11:12
cgmps for combination products: understanding and applying fda’s draft guidance - intro
-
5:37
gdufa ii training - pre anda product development meetings, robert lionberger
-
17:44
overview of comparative analyses - clinical perspective (19of35) complex generics – sep. 25-26, 2019
-
14:48
comparative analyses: injectable combination products (21of35) complex generics – sep. 25-26, 2019
-
1:00:28
writing the “indications and usage” section of labeling: fda’s new draft guidance – sep. 27, 2018
Clip.africa.com - Privacy-policy